Delivery Order SPE2DR25D9231-SPE2DR26FHPB1
Award Date 3/4/26
Potential Completion Date 3/25/26
Potential Value $6.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for YF-VAX 1 dose vials with a ceiling value of $62,954.00, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract established under a broader $30.3 billion acquisition strategy, authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials with a ceiling value of $10,072.64, with ultimate completion by March 27, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling spanning December 31, 2036. PPV-G GEN V authorizes firm fixed-price delivery orders for...
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is...
- The Defense Logistics Agency issued a $12,590.80 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, for YF-VAX 1 dose vials, with a ceiling value of $3,147.70. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. Place of...
- The Defense Logistics Agency issued a $25,181.60 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 27, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. Place of performance is...
- The Defense Logistics Agency issued a $3,147.70 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for YF-VAX 1-dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare operations...
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1-dose vials under the firm fixed-price Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a Defense Logistics Agency initiative authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,259.08 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...